Skip to main content

Table 1 Patient demographics

From: Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study

 

Control group

(n = 28)

CVVH group

(n = 29)

P value

Age

38 ± 18

27 ± 8

0.06

Percentage TBSA

58 ± 18

64 ± 18

0.21

Percentage full thickness

43 ± 27

49 ± 22

0.37

Inhalation injury

61%

41%

0.14

ISS

36 ± 14

35 ± 13

0.80

APACHE II#

36 ± 8

35 ± 5

0.76

MODS#

13 ± 4

12 ± 3

0.53

SOFA#

13 ± 4

13 ± 3

0.87

AKIN stage 3

71%

70%

0.84

BUN (mg/dl)*

58 ± 26

46 ± 24

0.07

Creatinine (mg/dl)*

2.8 ± 1

2.9 ± 2

0.88

Hospital day of T0

23 ± 26

17 ± 24

0.21

Septic shock

43%

42%

0.94

Shock (all cause)

68%

72%

0.50

ALI/ARDS

71%

55%

0.20

  1. All values calculated as means ± standard deviation. # Calculated at T0. * Measured on T0 – day of continuous renal replacement therapy initiation, diagnosis of renal failure or nephrology consultation.
  2. AKIN = acute kidney injury network; ALI = acute lung injury; APACHE = acute physiology and chronic health evaluation; ARDS = acute respiratory distress syndrome; BUN = blood urea nitrogen; CVVH = continuous venovenous hemofiltration; ISS = injury severity score; MODS = multiple organ dysfunction score; SOFA = sequential organ failure assessment; TBSA = total body surface area.